Sodium 4-Phenylbutyrate
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Children's Hospital of Philadelphia
Overview
Sodium 4-Phenylbutyrate is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Sodium 4-Phenylbutyrate clinical trials
Explore related
Medical disclaimer. This page summarizes research about Sodium 4-Phenylbutyrate for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.